since l-dopa in combination with a decarboxylase inhibitor is currently the most effective therapy available for treatment of parkinson 's disease , the authors compare the actual causes of death in a large series of treated parkinson patients with a normal population and with previous studies .
C0023570
l-dopa
C0030567
parkinson 's disease